Ostrich Pharma USA

Ostrich Pharma USA is a biotechnology company that leverages the unique immune system of ostriches to produce high-titer antibodies for therapeutic and diagnostic applications. The company's proprietary platform involves immunizing ostriches and extracting antibodies (IgY) from their eggs, a process that is significantly more efficient and scalable than traditional mammalian antibody production. Their product portfolio includes antibody-infused face masks and nasal sprays designed to neutralize viruses like SARS-CoV-2 and influenza, as well as specialized skincare products targeting acne and hair loss. Ostrich Pharma USA also explores treatments for gastrointestinal infections such as Helicobacter pylori. By providing a cost-effective and rapid response to emerging infectious diseases, the company aims to enhance global public health through innovative avian-derived biologics.